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Purpose: Hypothermia adversely affects the coagulation that could be of clinical 
significance in patients receiving clopidogrel. We evaluated the influence of hypo-
thermia on transfusion requirements in patients undergoing isolated off-pump coro-
nary artery bypass surgery (OPCAB) who continued clopidogrel use within 5 days 
of surgery. Materials and Methods: Protocol-based, prospectively entered data of 
369 patients were retrospectively reviewed. The time-weighted average of intraoper-
ative temperatures and the temperature upon ICU admission (TWA-temp) was as-
sessed. Patients were divided into normothermia (≥36°C, n=224) and hypothermia 
(<36°C, n=145) group. The transfusion requirement for perioperative blood loss was 
assessed and compared. Results: Patients with hypothermia were older and had 
lower body surface area (BSA) than patients with normothermia. Age and BSA ad-
justed transfusion requirement was significantly larger in the hypothermia group 
[patients requiring transfusion: 64% versus 48%, p=0.003; number of units: 0 (0-2) 
units versus 2 (0-3) units, p=0.002]. In multivariate analysis of predictors of periop-
erative multiple transfusion requirements, hypothermia was identified as an indepen-
dent risk factor along with age, female gender, BSA, chronic kidney disease, and 
congestive heart failure. Conclusion: Hypothermia was associated with increased 
transfusion requirement in patients undergoing OPCAB who received clopidogrel in 
proximity to surgery. Considering the high prevalence and the possibility of hypo-
thermia being a modifiable risk factor, aggressive measures should be undertaken to 
maintain normothermia in those patients.
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INTRODUCTION
With an increasing amount of evidence suggesting an ischemic benefit of some de-
gree of platelet inhibition at the time of coronary artery bypass graft surgery (CABG), 
off-pump coronary artery bypass surgery (OPCAB) is gaining renewed interest in 
patients who continue clopidogrel as it is devoid of platelet dysfunction or throm-
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>5 days before surgery (n=166), preexisting hypothermia 
(<36°C) or hyperthermia (>38°C, n=1), already enrolled in 
another randomized controlled trial (n=207), required 
emergent or salvage operations (n=21), required emergent 
conversion to an on-pump procedure (n=2), a postoperative 
temperature >38°C (n=2). After careful examination of the 
clinical data, 369 patients were enrolled and analyzed.
All patients received standard perioperative care, which 
was described previously.12 Briefly, standard monitoring in-
cluded a pulmonary artery (PA) catheter and transesopha-
geal echocardiography. Anesthesia consisted of sufentanil 
and sevoflurane, and a median sternotomy was performed 
in all surgical procedures. A cell salvage device was used 
intraoperatively in all patients and the salvaged blood was 
returned to the patient before the end of surgery. In all pa-
tients, a fluid warmer, a warm mattress, and a forced warm-
air blanket were used to maintain blood temperature be-
tween 36°C and 37°C which was measured by the PA 
catheter. During grafting, activated coagulation time was 
maintained around 250 sec using heparin (80 U/kg), and 
was neutralized using protamine after completion of the 
graft. After surgery, all patients were transferred to the ICU. 
During the perioperative period, packed erythrocytes were 
transfused when the hematocrit was less than 25%. Patients 
received fresh frozen plasma when the postoperative inter-
national normalized ratio was ≥1.5 with a rate of bleeding 
>200 mL/hr for two consecutive hours. Platelet concen-
trates were transfused when the postoperative platelet count 
was below 50000/mm3 with a same rate of bleeding as de-
scribed above. All data were retrieved from a protocol-
based, and the prospectively entered institutional OPCAB 
database.
Variables
Assessed preoperative variables included demographic data; 
the presence of diabetes mellitus (DM), hypertension, con-
gestive heart failure (New York Heart Association class III 
or IV), left ventricular ejection fraction (LVEF), chronic 
kidney disease (serum creatinine >1.4 mg/dL), or left main 
disease (>70% stenosis); history of recent myocardial in-
farction (MI) within the past week of surgery; as well as he-
matocrit level and medications. The number of patients 
who received clopidogrel within 2 days of surgery was also 
assessed.
Assessed operative variables included the duration of sur-
gery, number of grafts performed, use of saphenous vein 
grafts, vasopressor requirement (amount of norepinephrine 
bocytopenia inherent to cardiopulmonary bypass (CPB).1-3 
Still, continued dual antiplatelet therapy carries the risk of 
hemorrhagic complications. Notwithstanding the clear as-
sociation between the transfusion of allogeneic blood prod-
ucts and adverse outcome in cardiac surgical patients, any 
modifiable risk factors should be sought and corrected.4
Hypothermia is frequently encountered during and/or af-
ter surgical procedures requiring admission to the intensive 
care unit (ICU).5 Although hypothermia is known to de-
crease the metabolic demand of the body and provide toler-
ance to ischemia, it is also associated with deleterious phys-
iologic alterations. Hypothermia results in coagulopathy,6 
acidosis with a leftward shift of the oxygen-hemoglobin 
dissociation curve,7 impaired immune function/infectious 
complications,8 and arrhythmias/hemodynamic instability.9 
Indeed, previous studies depicted the predictive role of hy-
pothermia at the time of ICU admission on adverse out-
comes after CABG.10,11
However, no previous study has addressed the relation-
ship between hypothermia and transfusion requirement in 
patients undergoing OPCAB. This is of interest since hypo-
thermia is potentially modifiable risk factor of bleeding and 
transfusion requirement. The core temperature of a post-sur-
gical patient at the time of ICU admission should be influ-
enced by intraoperative temperature changes considering the 
temporal relation. As most of the perioperative bleeding and 
transfusion usually occur within a few hours after surgery, 
the time-weighted average of intraoperative temperatures 
and the temperature upon ICU admission (TWA-temp) may 
be associated with an increased transfusion requirement.
The aim of this retrospective study was to evaluate the 
influence of TWA-temp on perioperative transfusion re-
quirement in patients undergoing OPCAB who continued 
clopidogrel use within 5 days of surgery. 
MATERIALS AND METHODS
　　　
Patients and perioperative management
After approval by the Institutional Review Board, we retro-
spectively reviewed electronic medical records of 768 con-
secutive patients who underwent elective, isolated OPCAB 
between January 2009 and February 2012 at the Cardiovas-
cular Hospital of Yonsei University College of Medicine. 
The need to obtain written consent from patients was waived 
by the Institutional Review Board. Exclusion criteria for 
patients were as follows: discontinued clopidogrel therapy 
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<0.05 between patients who required multiple transfusions 
or not were first introduced to a univariate logistic regres-
sion analysis. Variables with a p value of <0.05 in the uni-
variate analysis were further introduced to multivariate lo-
gistic regression analysis to identify independent risk factors. 
Odds ratios and associated 95% confidence interval were 
estimated. The same methods were applied to identify risk 
factors of composite of morbidity/mortality endpoints. Con-
tinuous variables are shown as mean±standard deviation 
(SD) or median (interquartile range), categorical variables 





Of the 369 patients, 145 patients were classified as having 
hypothermia (range; 34.2-35.9°C) based on their TWA-
temp measured by the PA catheter during the surgery and 
upon arrival at the ICU. Accordingly, 224 patients were clas-
sified as having normothermia (range; 36-37.5°C). Compari-
sons of preoperative variables between patients with hypo-
thermia and normothermia are listed in Table 1. Patients with 
hypothermia were older and had lower body surface area 
than patients with normothermia. Other characteristics in-
cluding the presence of co-morbid diseases and left ventricu-
lar ejection fraction were all similar between the groups.
Operative characteristics and postoperative outcome vari-
ables are listed in Table 2. Operative data including the num-
ber of grafts performed were all similar between the groups. 
In-hospital mortality rate was significantly higher in the hy-
pothermia group (4 vs. 0), two patients died due to aspiration 
pneumonia and two patients due to cardiac failure. However, 
we found no difference between other outcome variables in-
cluding the endpoints of composite morbidity/mortality be-
tween the groups. The trend towards a longer length of hos-
pital stay in the hypothermia group was observed when 
compared with the normothermia group.
Age and body surface area adjusted comparisons of peri-
operative blood loss and transfusion requirement are listed 
in Table 3. Overall, a significantly larger percentage of pa-
tients in the hypothermia group required packed erythro-
cytes transfusion compared with the normothermia group. 
In addition, significantly more units of packed erythrocytes 
were transfused in the hypothermia group compared with 
the normothermia group. The percentage of patients requir-
ing multiple transfusions was significantly higher in the hy-
infused and number of patients requiring vasopressin), and 
transfusion requirement. The amount of re-infused blood 
volume from the cell salvage device was considered as the 
intraoperative blood loss.
Assessed postoperative variables included highest cre-
atine kinase-MB, number of patients who required milri-
none, amount of blood loss, transfusion requirement, length 
of stay in the ICU and hospital. Composite morbidity/mor-
tality endpoints were also assessed and were defined as 
having more than one of the following: MI (an increase in 
creatine kinase-MB 5 times or greater over the upper nor-
mal limit, when associated with newly developed Q wave 
or left bundle branch block on electrocardiogram),13 perma-
nent stroke, acute kidney injury (increase of serum creati-
nine to >2.0 mg/dL, 2 times higher than most recent preop-
erative creatinine level or a new requirement for dialysis), 
hemostatic re-exploration, deep sternal wound infection, 
ventilator care >48 hr, and in-hospital mortality.14
Temperature measurements
The TWA-temp for each patient was calculated as the area 
under the curve divided by the time from first to last mea-
surement. The time points included were: after anesthetic 
induction, Y-graft construction, during grafting, sternal clo-
sure, and upon arrival at the ICU.
Study end points
The primary endpoint was to compare the amount of periop-
erative blood loss and transfusion requirement between pa-
tients with hypothermia (TWA-temp <36°C) and normo-
thermia (TWA-temp ≥36°C). Independent risk factors of 
multiple transfusion requirements (≥2 units of packed eryth-
rocytes) were also analyzed.
The secondary endpoint was to compare the incidence of 
composite morbidity/mortality endpoints between patients 
with hypothermia and normothermia. Independent risk fac-
tors of composite of morbidity/mortality endpoints were 
also analyzed.
Statistical analysis
All analyses were performed with SPSS 15.0 (SPSS Inc., 
Chicago, IL, USA). Intergroup comparisons were done 
with t-test, Mann-Whitney U test, ANCOVA (for adjust-
ment of age and body surface area), and χ2 test or Fisher’s 
exact test as appropriate. To identify independent predictors 
of a multiple transfusion requirements, logistic regression 
models were used. Variables demonstrating a p value of 
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disease were identified as independent predictors (Table 5). 
DISCUSSION
In the current retrospective study, we found that hypothermia 
(TWA-temp measured during the intraoperative period and 
upon arrival at the ICU) was associated with an increased 
pothermia group compared with the normothermia group.
In the multivariate analysis of predictors of perioperative 
multiple transfusion requirements, hypothermia was identi-
fied as an independent risk factor along with age, female 
gender, body surface area, chronic kidney disease and con-
gestive heart failure (Table 4).
In the multivariate analysis of predictors of composite of 
morbidity/mortality endpoints, recent MI and chronic kidney 
Table 1. Preoperative Patients’ Characteristics
 Normothermia (n=224) Hypothermia (n=145) p value
Age (yrs) 64.5±8.4 66.3±8.3 0.040
Body surface area (m2)   1.71±0.17   1.67±0.18 0.018
Female sex   72 (32)   51 (35) 0.555
Diabetes mellitus 107 (48)   62 (43) 0.335
Hypertension 136 (61) 100 (69) 0.119
Chronic kidney disease   28 (13)   22 (15) 0.468
Congestive heart failure   30 (13)   14 (10) 0.279
Myocardial infarction within 1 wk 15 (7)   9 (6) 0.852
Left ventricular ejection fraction (%)   54±15   55±14 0.615
Left main disease   51 (23)   33 (23) 0.998
Hematocrit (%) 37±5 38±4 0.511
Medications
    Clopidogrel within 2 days   69 (31)   49 (34) 0.548
    Beta blockers 136 (61)   94 (65) 0.437
    Renin-angiotensin system inhibitors 128 (60)   83 (53) 0.186
    Calcium channel blockers   85 (38)   68 (47) 0.078
Values are mean±SD or number of patients (%). Hypothermia was defined as time-weighted average of intraoperative temperatures and the temperature 
upon intensive care unit admission <36°C.
Table 2. Operative Data and Postoperative Outcome
Normothermia (n=224) Hypothermia (n=145) p value
Operative data
    Operation time (mins) 314±53 319±52 0.393
    Number of grafts   3.3±0.8   3.3±0.7 0.585
    Use of vein graft   55 (25) 41 (29) 0.432
    Norepinephrine during grafting (µg)   169±139   170±133 0.910
    Vasopressin   91 (41) 62 (43) 0.696
Postoperative data
    Highest creatine kinase-MB   11.9±12.2   11.5±15.3 0.761
    Milrinone   45 (21) 31 (22) 0.805
    Intensive care unit stay (days)   2.8±3.3   2.7±2.0 0.633
    Hospital stay (days)   15.0±10.5   18.6±19.2 0.065
    Composite of morbidity/mortality endpoints   62 (28) 35 (24) 0.470
        Myocardial infarction 14 (6) 9 (6) 0.983
        Permanent stroke      1 (0.5) 0 (0) 1.000
        Acute kidney injury   59 (27) 31 (22) 0.273
        Hemostatic re-operation   1 (1) 3 (2) 0.305
        Deep sternal wound infection   8 (4) 2 (1) 0.327
        Ventilator care >48 h   9 (4) 1 (1) 0.096
        In-hospital mortality   0 (0) 4 (3) 0.023
Values are mean±SD or number of patients (%). 
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in the hypothermia group, no association was observed be-
tween hypothermia and a composite of morbidity/mortality 
endpoints. 
Dual antiplatelet therapy comprised of aspirin and clopi-
dogrel has long been accepted as an essential therapy for 
perioperative transfusion requirement in patients undergo-
ing OPCAB who continued clopidogrel use within 5 days 
of surgery. Moreover, hypothermia was also found to be an 
independent risk factor of perioperative multiple transfu-
sion requirements. Although the mortality rate was higher 
Table 3. Perioperative Blood Loss and Transfusion Requirement 
Normothermia (n=224) Hypothermia (n=145) p value
Intraoperative
Blood loss (mL) 237±174   230±146 0.719
    Packed erythrocytes (unit)      0 (0-1)    0 (0-1) 0.009
    Patients requiring packed erythrocytes   66 (30) 52 (36) 0.208
Postoperative
    Blood loss (mL) 794±432   900±332 0.165
    Packed erythrocytes (unit)      0 (0-1)    1 (0-1) 0.028
    Patients requiring packed erythrocytes   73 (33) 72 (50) 0.001
    Fresh frozen plasma (unit)      0 (0-0)    0 (0-0) 0.999
    Patients requiring fresh frozen plasma   38 (17) 34 (23) 0.130
    Platelet concentrates (unit)      0 (0-0)      6 (6-14) 0.028
    Patients requiring platelet concentrates   3 (1) 4 (3) 0.319
Perioperative (intraoperative+postoperative)
    Blood loss (mL) 918±511 1176±444 0.235
    Packed erythrocytes (unit)      0 (0-2)    2 (0-3) 0.002
    Patients requiring packed erythrocytes 107 (48) 91 (64) 0.003
    Patients requiring ≥2 units of packed erythrocytes   86 (39) 73 (51) 0.019
p values are age and body surface area adjusted. 
Table 4. Predictive Power of Risk Factors for Perioperative Multiple Transfusion Requirements According to Logistic Regres-
sion Analysis
Variables
Univariate analysis Multivariate analysis
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Age 1.08 (1.05-1.12) <0.001 1.06 (1.02-1.09) 0.001
Female gender 3.47 (2.20-5.46) <0.001 2.09 (1.12-3.88) 0.020
Body surface area 0.03 (0.01-0.09) <0.001 0.12 (0.02-0.74) 0.022
Diabetes mellitus 1.84 (1.21-2.80)   0.004 1.41 (0.87-2.27) 0.165
Hypertension 1.68 (1.08-2.61)   0.021 1.34 (0.80-2.23) 0.265
Chronic kidney disease 2.82 (1.50-5.29)   0.001 2.98 (1.48-6.00) 0.002
Congestive heart failure 2.95 (1.50-5.81)   0.002 2.11 (1.00-4.44) 0.049
Clopidogrel within 2 days of surgery 1.55 (0.97-2.44)   0.098
Hypothermia 1.74 (1.14-2.65)   0.010 1.49 (1.07-2.42) 0.011
CI, confidence interval.
Table 5. Predictive Power of Risk Factors for the Composite of Morbidity/Mortality Endpoints According to Logistic Regres-
sion Analysis 
Variables
Univariate analysis Multivariate analysis
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Diabetes mellitus 2.01 (1.25-3.21)   0.004 1.55 (0.94-2.56)   0.086
Myocardial infarction within 1 wk 2.47 (1.43-4.28)   0.001 1.96 (1.04-3.67)   0.037
Chronic kidney disease 5.10 (2.74-9.50) <0.001 4.15 (2.16-7.96) <0.001
Left ventricular ejection fraction 0.98 (0.96-1.00)   0.010 0.97 (0.98-1.01)   0.996
Hypothermia 0.83 (0.51-1.34)   0.451
CI, confidence interval.
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coronary patients presenting for surgery with some degree 
of platelet inhibition to maximize the ischemic benefit of an-
tiplatelet therapy. Mild hypothermia was shown to counter-
act the platelet-inhibitory effect of clopidogrel, when clopi-
dogrel was administered concomitantly in the presence of 
hypothermia.24,25 However, binding of clopidogrel to the 
P2Y12 receptor is irreversible and the influence of hypo-
thermia on the clopidogrel’s platelet-inhibitory function in 
patients who already reached steady-state by previous con-
tinuous administration remains elusive.
In a previous study, even mild hypothermia (<0.5°C) has 
been shown to be associated with increased blood loss and 
transfusion requirement in patients undergoing hip arthro-
plasty although none of the patients studied were exposed 
to antiplatelet therapy in proximity to surgery.26 Of particu-
lar interest, a follow-up study reported that aggressive warm-
ing reduced blood loss during the same surgical procedure 
implicating that hypothermia may be a modifiable risk fac-
tor of perioperative bleeding and transfusion requirement.27 
As of yet, no comprehensive data exist regarding the influ-
ence of hypothermia on bleeding and transfusion require-
ment in patients undergoing OPCAB who continued dual 
antiplatelet therapy within 5 days of surgery.
In the current study, despite the application of a fluid 
warmer, warm mattress, and a forced warm-air blanket in 
all patients, 39% of the patients were hypothermic. The 
amount of the perioperative blood loss was greater in the 
hypothermia group; however, this finding was without sta-
tistical significance. This may be attributable to the inaccu-
rate assessment of intraoperative blood loss. In the current 
study, intraoperative blood loss was assessed only as the 
amount of blood salvaged by a cell salvage device not ac-
counting for the other unmeasured and insensible blood loss. 
Still, transfusion requirement was significantly greater in 
patients with hypothermia despite that other risk factors of 
bleeding and transfusion requirement including the baseline 
hematocrit values. In addition, the number of grafts per-
formed was similar between patients with normothermia 
and hypothermia. Moreover, hypothermia was found to be 
an independent risk factor of multiple transfusion require-
ments along with the previously known factors such as age, 
female gender, body surface area, chronic kidney disease, 
and congestive heart failure. Thus, the results of the current 
study clearly implicate the association between hypother-
mia and transfusion requirement in patients undergoing 
OPCAB who continued dual antiplatelet therapy.
Of interest and in contrast to the findings of the previous 
patients with coronary artery disease.15 Accordingly, an in-
creasing number of patients presenting for CABG are ex-
posed to platelet inhibition and are at increased risk of hem-
orrhagic complications. Yet, considering the existence of an 
ischemic and even a mortality benefit imposed by the anti-
platelet therapy outweighing the bleeding risk, recent litera-
ture advocates the importance of some degree of platelet in-
hibition at the time of CABG.1,3 In order to maximize the 
ischemic benefit and minimize the bleeding risk, OPCAB 
has been proposed as an alternative technique to on-pump 
CABG, as it is associated with limited deterioration in plate-
let function and counts frequently observed after CPB.16 
However, several studies backed the safety of OPCAB in 
patients who continued clopidogrel in terms of bleeding and 
transfusion requirement, thus transfusion is not uncommon 
in OPCAB.2,17,18
Transfusion of allogeneic blood products is known to be 
associated with adverse outcomes that carry risks far be-
yond that of transmitting infectious diseases.4 Thus identifi-
cation of risk factors would be of major clinical importance 
not only for risk stratification, but also for the future devel-
opment of therapeutic measures aimed at modifying the 
identified risk factors resulting in improved patients’ out-
come. Previously known risk factors of bleeding and trans-
fusion requirement in patients undergoing CABG are multi-
ple. These include age, female gender, weight, DM, chronic 
kidney disease, poor LVEF, preoperative hematocrit value, 
and a history of MI.18,19 Yet, most of these factors are not 
readily amenable to modifications at the time of CABG.
Hypothermia is a frequently accompanied phenomenon 
in patients undergoing major surgical procedures. In the 
case of OPCAB, 46.7% of the patients were reported to be 
hypothermic after leaving the operating room.11 Apart from 
its beneficial influence of providing organ protection against 
ischemia-reperfusion injury, hypothermia is associated with 
a multitude of adverse physiologic alterations. In terms of 
coagulation, hypothermia has been shown to be associated 
with platelet dysfunction as well as a mild decrease in plate-
let counts.20 Proposed mechanisms include impaired throm-
boxane A2 release and inhibited exposure of P-selectin on 
the platelet surface.21 Moreover, hypothermia has been 
shown to inhibit coagulation enzyme activities delaying the 
onset of thrombin generation.22 Hypothermia is also often ac-
companied by acidosis, which in turn results in profound in-
hibition of thrombin generation in the propagation phase.22,23 
These adverse influences of hypothermia, especially on 
platelet function, may exert significant clinical influence in 
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line hematocrit level was similar between both groups and 
that all other operative data were similar, we can only spec-
ulate that intraoperative blood loss may have been greater 
in the hypothermia group.
In conclusion, perioperative hypothermia assessed by 
TWA-temp was associated with an increased transfusion 
requirement in patients undergoing OPCAB who continued 
dual antiplatelet therapy until 5 days of surgery. Consider-
ing the high prevalence of hypothermia and the possibility 
of hypothermia being a modifiable risk factor of transfusion 
requirement, more aggressive measures should be under-
taken to maintain normothermia in those patients.
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